Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
69
CNVS Quote, Financials, Valuation and Earnings
Last price:
$6.51
Seasonality move
:
-4.71%
Day range:
$6.45 - $6.94
52-week range:
$0.72 - $7.39
Dividend yield:
0%
P/E ratio:
72.89x
P/S ratio:
1.42x
P/B ratio:
3.19x
Volume:
214.4K
Avg. volume:
451.7K
1-year change:
643.84%
Market cap:
$112.2M
Revenue:
$78.2M
EPS (TTM):
-$1.14
Analysts' Opinion
-
Consensus RatingCineverse has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $9.50, Cineverse has an estimated upside of 44.82% from its current price of $6.49.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $9.00 representing 100% downside risk from its current price of $6.49.
Fair Value
-
According to the consensus of 2 analysts, Cineverse has 44.82% upside to fair value with a price target of $9.50 per share.
CNVS vs. S&P 500
-
Over the past 5 trading days, Cineverse has underperformed the S&P 500 by -7.01% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cineverse does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cineverse has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Cineverse reported revenues of $40.7M.
Earnings Growth
-
Cineverse has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Cineverse reported earnings per share of $0.34.
Enterprise value:
100.9M
EV / Invested capital:
--
Price / LTM sales:
1.42x
EV / EBIT:
12.25x
EV / Revenue:
1.29x
PEG ratio (5yr expected):
-0.26x
EV / Free cash flow:
6.21x
Price / Operating cash flow:
6.84x
Enterprise value / EBITDA:
8.38x
Gross Profit (TTM):
$38.7M
Return On Assets:
-17.05%
Net Income Margin (TTM):
-16.52%
Return On Equity:
-35.17%
Return On Invested Capital:
-29.81%
Operating Margin:
23.16%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $68M | $49.1M | $78.2M | $9.9M | $15.6M | |
| Gross Profit | $31.7M | $30M | $39.4M | $7.8M | $8.5M | |
| Operating Income | -$6.4M | -$1.7M | $7.9M | $29K | $2.1M | |
| EBITDA | -$4.5M | -$16.4M | $12M | -$13.4M | $3.2M | |
| Diluted EPS | -$1.14 | -$1.82 | $0.09 | -$1.19 | $0.04 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $43.1M | $52.2M | $37.6M | $32.7M | $38.1M | |
| Total Assets | $75.4M | $104.6M | $88M | $64.4M | $72.5M | |
| Current Liabilities | $57.4M | $57M | $45.3M | $31.2M | $34.4M | |
| Total Liabilities | $59.6M | $63.7M | $48.9M | $32.2M | $34.7M | |
| Total Equity | $15.9M | $41M | $39.1M | $32.2M | $37.8M | |
| Total Debt | $11.9M | -- | $4.9M | $6.3M | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$8.8M | -$10.6M | $17.4M | -$1.3M | $12.4M | |
| Cash From Investing | -$1.3M | -$531K | -$635K | -$49K | $20K | |
| Cash From Financing | $4.2M | $9.1M | -$8M | $982K | -$4.6M | |
| Free Cash Flow | -$10.1M | -$11.7M | $16.2M | -$1.7M | $12.4M | |
CNVS
Sector
Market Cap
$112.2M
$85.7M
Price % of 52-Week High
88.77%
71.43%
Dividend Yield
0%
0%
Shareholder Yield
0.76%
3.73%
1-Year Price Total Return
637.08%
-9.01%
Beta (5-Year)
1.361
0.572
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.64
200-day SMA
Buy
Level
$3.45
Bollinger Bands (100)
Buy
Level
2.66 - 4.82
Chaikin Money Flow
Sell
Level
-72.1M
20-day SMA
Buy
Level
$5.50
Relative Strength Index (RSI14)
Buy
Level
72.98
ADX Line
Buy
Level
63.1
Williams %R
Neutral
Level
-23.8335
50-day SMA
Buy
Level
$4.27
MACD (12, 26)
Buy
Level
0.75
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
116.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-7.2231)
Buy
CA Score
(Annual)
Level (0.646)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-2.5497)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.
Stock Forecast FAQ
In the current month, CNVS has received 2 Buy ratings 0 Hold ratings, and 0 Sell ratings. The CNVS average analyst price target in the past 3 months is $9.50.
-
Where Will Cineverse Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cineverse share price will rise to $9.50 per share over the next 12 months.
-
What Do Analysts Say About Cineverse?
Analysts are divided on their view about Cineverse share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cineverse is a Sell and believe this share price will drop from its current level to $9.00.
-
What Is Cineverse's Price Target?
The price target for Cineverse over the next 1-year time period is forecast to be $9.50 according to 2 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is CNVS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cineverse is a Buy. 2 of 2 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CNVS?
You can purchase shares of Cineverse via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cineverse shares.
-
What Is The Cineverse Share Price Today?
Cineverse was last trading at $6.51 per share. This represents the most recent stock quote for Cineverse. Yesterday, Cineverse closed at $6.49 per share.
-
How To Buy Cineverse Stock Online?
In order to purchase Cineverse stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
